海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300584 海辰药业

未开盘 10-21 09:30:00

{"stockData":{"symbol":"300584","market":"SZ","secType":"STK","nameCN":"海辰药业","latestPrice":28.17,"timestamp":1792545156000,"preClose":28.17,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":82131500,"shares":120000000,"eps":0.3748,"marketStatus":"未开盘","change":0,"latestTime":"10-21 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.3748,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792546200000},"marketStatusCode":0,"adr":0,"adjPreClose":28.17,"symbolType":"stock","openAndCloseTimeList":[[1792546200000,1792553400000],[1792558800000,1792566000000]],"highLimit":30.99,"lowLimit":25.35,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120000000,"isCdr":false,"pbRate":3.15,"roa":"--","peRate":75.160085,"roe":"3.0%","epsLYR":0.3505,"committee":0,"marketValue":3380000000,"turnoverRate":0,"status":2,"floatMarketCap":2314000000},"requestUrl":"/m/hq/s/300584/tweets","defaultTab":"tweets","newsList":[{"id":"2675392983","title":"海辰药业（300584）10月13日主力资金净卖出907.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675392983","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675392983?lang=zh_cn&edition=full","pubTime":"2026-10-13 15:34","pubTimestamp":1791876890,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月13日收盘，海辰药业报收于30.8元，下跌2.69%，换手率7.3%，成交量6.0万手，成交额1.81亿元。10月13日的资金流向数据方面，主力资金净流出907.01万元，占总成交额5.02%，游资资金净流出1113.11万元，占总成交额6.16%，散户资金净流入2020.12万元，占总成交额11.17%。海辰药业主营业务：化学制剂、原料药及中间体的研发、生产、销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300020597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674054822","title":"海辰药业（300584）10月12日主力资金净卖出1538.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674054822","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674054822?lang=zh_cn&edition=full","pubTime":"2026-10-12 15:33","pubTimestamp":1791790429,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月12日收盘，海辰药业报收于31.65元，下跌5.58%，换手率7.64%，成交量6.28万手，成交额2.03亿元。10月12日的资金流向数据方面，主力资金净流出1538.24万元，占总成交额7.58%，游资资金净流出78.3万元，占总成交额0.39%，散户资金净流入1616.54万元，占总成交额7.97%。海辰药业主营业务：化学制剂、原料药及中间体的研发、生产、销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200014969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674457348","title":"股市必读：海辰药业(300584)股东户数2.07万户，较上期增加7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674457348","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674457348?lang=zh_cn&edition=full","pubTime":"2026-10-12 02:41","pubTimestamp":1791744069,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，海辰药业报收于33.52元，下跌0.83%，换手率11.25%，成交量9.24万手，成交额3.07亿元。股本股东变化：截至2026年9月30日股东户数为2.07万户，较9月10日增加7.14%。股本股东变化股东户数变动截至2026年9月30日公司股东户数为2.07万户，较9月10日增加1377.0户，增幅为7.14%；户均持股数量由6224.0股减少至5809.0股，户均持股市值为18.11万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674830880","title":"海辰药业：截至9月30日收盘，公司股东户数为20656户","url":"https://stock-news.laohu8.com/highlight/detail?id=2674830880","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674830880?lang=zh_cn&edition=full","pubTime":"2026-10-09 11:36","pubTimestamp":1791517000,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至9月30日公司股东人数是多少，谢谢海辰药业回复：尊敬的投资者您好，截至9月30日收盘，公司股东户数为20656户，感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900015144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673179720","title":"股市必读：海辰药业(300584)股东户数1.93万户，较上期减少5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673179720","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673179720?lang=zh_cn&edition=full","pubTime":"2026-10-08 03:10","pubTimestamp":1791400224,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，海辰药业报收于31.18元，上涨1.56%，换手率4.83%，成交量3.97万手，成交额1.24亿元。当日关注点交易信息汇总：9月30日主力资金净流出143.19万元，占总成交额1.15%。股本股东变化：截至9月10日股东户数为1.93万户，较8月31日减少5.02%，户均持股数量增至6224.0股。谢谢董秘： 尊敬的投资者您好，截至9月10日收盘，公司股东户数为19279户，感谢关注！公司三季报将于10月23日披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671007277","title":"海辰药业(300584)9月10日股东户数1.93万户，较上期减少5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671007277","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671007277?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:28","pubTimestamp":1790760517,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海辰药业披露，截至2026年9月10日公司股东户数为1.93万户，较8月31日减少1018.0户，减幅为5.02%。在化学制药行业个股中，海辰药业股东户数低于行业平均水平，截至9月10日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年8月31日至2026年9月10日，海辰药业区间跌幅为4.12%，在此期间股东户数减少1018.0户，减幅为5.02%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000027508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671276364","title":"海辰药业：截至9月10日收盘，公司股东户数为19279户","url":"https://stock-news.laohu8.com/highlight/detail?id=2671276364","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671276364?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:06","pubTimestamp":1790751985,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)09月30日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截止9月10日最新股东户数是多少？谢谢海辰药业回复：尊敬的投资者您好，截至9月10日收盘，公司股东户数为19279户，感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000018693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671275011","title":"海辰药业：公司电解液添加剂VC产品三季度仍维持即产即销状态","url":"https://stock-news.laohu8.com/highlight/detail?id=2671275011","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671275011?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:03","pubTimestamp":1790751791,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)09月30日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司VC电解液添加剂产销情况如何啊？三季度正式放量了吗？海辰药业回复：尊敬的投资者您好，公司电解液添加剂VC产品三季度仍维持即产即销状态，具体销量将在三季报中披露，敬请关注！公司三季报将于10月23日披露。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000018654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668194047","title":"海辰药业(300584.SZ)拟收购安庆汇辰少数股东股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2668194047","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668194047?lang=zh_cn&edition=full","pubTime":"2026-09-18 19:00","pubTimestamp":1789729218,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海辰药业 发布公告，公司控股子公司安庆汇辰科技有限公司少数股东顾玉琴、钱德民、陆士平及蒋金元拟转让其合计持有的安庆汇辰25%股权。本次收购完成后，公司对安庆汇辰的持股比例将由75%增加至100%，安庆汇辰将成为公司全资子公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498134.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668088944","title":"海辰药业：拟收购安庆汇辰25%股权至100%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668088944","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668088944?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:44","pubTimestamp":1789724666,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666589778","title":"海辰药业(300584)8月31日股东户数2.03万户，较上期减少0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666589778","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666589778?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:28","pubTimestamp":1788946130,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海辰药业披露，截至2026年8月31日公司股东户数为2.03万户，较7月31日减少128.0户，减幅为0.63%。在化学制药行业个股中，海辰药业股东户数低于行业平均水平，截至8月31日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年7月31日至2026年8月31日，海辰药业区间跌幅为1.71%，在此期间股东户数减少128.0户，减幅为0.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900029409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666305733","title":"海辰药业：截至8月31日收盘，公司股东户数为20297户","url":"https://stock-news.laohu8.com/highlight/detail?id=2666305733","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666305733?lang=zh_cn&edition=full","pubTime":"2026-09-09 09:06","pubTimestamp":1788915974,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)09月08日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止至2026年8月31日股东人数是多少谢谢海辰药业回复：尊敬的投资者您好，截至8月31日收盘，公司股东户数为20297户，感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900008515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662750751","title":"海辰药业（300584）2026年中报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662750751","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662750751?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:43","pubTimestamp":1787697797,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期海辰药业发布2026年中报。截至本报告期末，公司营业总收入3.64亿元，同比上升18.01%，归母净利润3206.5万元，同比上升9.97%。按单季度数据看，第二季度营业总收入2.04亿元，同比上升22.84%，第二季度归母净利润1470.2万元，同比上升4.12%。本报告期海辰药业应收账款上升，应收账款同比增幅达39.1%。财报体检工具显示：建议关注公司现金流状况建议关注公司应收账款状况本文数据来源于海辰药业2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600011695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662738783","title":"海辰药业(300584)7月31日股东户数2.04万户，较上期减少4.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662738783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662738783?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:53","pubTimestamp":1787651631,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海辰药业披露，截至2026年7月31日公司股东户数为2.04万户，较7月10日减少941.0户，减幅为4.4%。在化学制药行业个股中，海辰药业股东户数低于行业平均水平，截至7月31日，化学制药行业平均股东户数为3.68万户。从股价来看，2026年7月10日至2026年7月31日，海辰药业区间跌幅为8.05%，在此期间股东户数减少941.0户，减幅为4.4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500037735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203674","title":"图解海辰药业中报：第二季度单季净利润同比增长4.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203674","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662203674?lang=zh_cn&edition=full","pubTime":"2026-08-25 02:14","pubTimestamp":1787595280,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业2026年中报显示，上半年度公司主营收入3.64亿元，同比上升18.01%；归母净利润3206.5万元，同比上升9.97%；扣非净利润3625.74万元，同比上升25.67%；其中2026年第二季度，公司单季度主营收入2.04亿元，同比上升22.84%；单季度归母净利润1470.2万元，同比上升4.12%；单季度扣非净利润1874.23万元，同比上升35.33%；负债率26.09%，投资收益-162.91万元，财务费用271.69万元，毛利率72.98%。财报数据概要请见下图:本文数据来源于海辰药业2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657451089","title":"海辰药业(300584)7月31日股东户数2.04万户，较上期减少4.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657451089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657451089?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:45","pubTimestamp":1785923155,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海辰药业披露，截至2026年7月31日公司股东户数为2.04万户，较7月10日减少941.0户，减幅为4.4%。在化学制药行业个股中，海辰药业股东户数低于行业平均水平，截至7月31日，化学制药行业平均股东户数为3.59万户。从股价来看，2026年7月10日至2026年7月31日，海辰药业区间跌幅为8.05%，在此期间股东户数减少941.0户，减幅为4.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500032523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657594162","title":"海辰药业：截至7月31日收盘，公司股东户数为20425户","url":"https://stock-news.laohu8.com/highlight/detail?id=2657594162","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657594162?lang=zh_cn&edition=full","pubTime":"2026-08-05 11:37","pubTimestamp":1785901027,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到7月31日公司股东人数是多少？谢谢海辰药业回复：尊敬的投资者您好，截至7月31日收盘，公司股东户数为20425户，感谢对海辰药业的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500017940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653451017","title":"海辰药业(300584)7月10日股东户数2.14万户，较上期减少2.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653451017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653451017?lang=zh_cn&edition=full","pubTime":"2026-07-23 17:56","pubTimestamp":1784800584,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海辰药业披露，截至2026年7月10日公司股东户数为2.14万户，较6月30日减少547.0户，减幅为2.5%。在化学制药行业个股中，海辰药业股东户数低于行业平均水平，截至7月10日，化学制药行业平均股东户数为3.58万户。从股价来看，2026年6月30日至2026年7月10日，海辰药业区间跌幅为5.02%，在此期间股东户数减少547.0户，减幅为2.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300036851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653713663","title":"海辰药业：截至7月10日收盘，公司股东户数为21366户","url":"https://stock-news.laohu8.com/highlight/detail?id=2653713663","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653713663?lang=zh_cn&edition=full","pubTime":"2026-07-23 11:42","pubTimestamp":1784778136,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)07月22日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问截至7月10日股东人数是多少？谢谢海辰药业回复：尊敬的投资者您好，截至7月10日收盘，公司股东户数为21366户，感谢对海辰药业的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300019833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652406225","title":"7月17日海辰药业跌11.67%，博时战略新材料主题混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652406225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652406225?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:54","pubTimestamp":1784278452,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日海辰药业跌11.67%，收盘报31.34元，换手率9.02%，成交量7.4万手，成交额2.42亿元。重仓海辰药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为博时基金的博时战略新材料主题混合A。博时战略新材料主题混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","159703","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792545211660,"stockEarnings":[{"period":"1week","weight":-0.0854},{"period":"1month","weight":-0.0986},{"period":"3month","weight":-0.1043},{"period":"6month","weight":-0.327},{"period":"1year","weight":-0.5006},{"period":"ytd","weight":-0.4377}],"compareEarnings":[{"period":"1week","weight":-0.0172},{"period":"1month","weight":-0.0451},{"period":"3month","weight":-0.034},{"period":"6month","weight":-0.0874},{"period":"1year","weight":-0.0333},{"period":"ytd","weight":-0.0588}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京海辰药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20656人(较上一季度增加7.14%)","perCapita":"3976股","listingDate":"2017-01-12","address":"江苏省南京市栖霞区经济技术开发区恒发路1号","registeredCapital":"12000万元","survey":"　　南京海辰药业股份有限公司的主营业务是化学制剂、原料药及中间体的研发、生产、销售。公司的主要产品是心脑血管类、锂电池电解液添加剂。","listedPrice":11.11},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海辰药业,300584,海辰药业股票,海辰药业股票老虎,海辰药业股票老虎国际,海辰药业行情,海辰药业股票行情,海辰药业股价,海辰药业股市,海辰药业股票价格,海辰药业股票交易,海辰药业股票购买,海辰药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}